Usefulness of erythropoietin and G-CSF during treatment for chronic hepatitis C with pegylated interferon: A clinical descriptive analysis.

被引：0
|
作者：
Lebray, P [1 ]
Pichard, AV [1 ]
Broissand, C [1 ]
Nalpas, B [1 ]
Sobesky, R [1 ]
Fontaine, H [1 ]
Pol, S [1 ]
机构：
[1] AP HP, Paris, France
来源：
HEPATOLOGY | 2002年 / 36卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1644
引用
收藏
页码：574A / 574A
页数：1
相关论文
共 50 条
  • [1] Mania during treatment of chronic hepatitis C with pegylated interferon and ribavirin
    Onyike, CU
    Bonner, JO
    Lyketsos, CG
    Treisman, GJ
    AMERICAN JOURNAL OF PSYCHIATRY, 2004, 161 (03): : 429 - 435
  • [2] Amantadine and interferon for treatment of chronic hepatitis C - A preliminary analysis.
    Ben-Ari, Z
    Zemel, R
    Kazatzker, A
    Manhaim, V
    Tur-Kaspa, R
    HEPATOLOGY, 1998, 28 (04) : 696A - 696A
  • [3] Pegylated Interferon and Ribavirin for the Treatment of Chronic Hepatitis C
    Kemp, William
    Roberts, Stuart
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2011, 3 : 137 - 150
  • [4] Weight loss during pegylated interferon and ribavirin treatment of chronic hepatitis C
    Seyam, MS
    Freshwater, DA
    O'Donnell, K
    Mutimer, DJ
    JOURNAL OF VIRAL HEPATITIS, 2005, 12 (05) : 531 - 535
  • [5] Autoimmune Thrombocytopenic Purpura during Pegylated Interferon α Treatment for Chronic Hepatitis C
    Kim, Soo Ryang
    Imoto, Susumu
    Kudo, Masatoshi
    Nakajima, Taisuke
    Ando, Kenji
    Mita, Keiji
    Fukuda, Katsumi
    Hong, Hyun Soo
    Lee, Yeong Ho
    Nakashima, Keiichi
    Shoji, Ikuo
    Nagano-Fujii, Motoko
    Hotta, Hak
    Hayashi, Yoshitake
    INTERNAL MEDICINE, 2010, 49 (12) : 1119 - 1122
  • [6] Use of G-CSF allows for optimal PEG-INF dosing during therapy for hepatitis C virus with pegylated interferon and ribaverin.
    Carey, E
    Rosati, M
    Anderson, M
    Khatib, MA
    Vargas, H
    Harrison, ME
    Douglas, D
    Rakela, J
    Balan, V
    HEPATOLOGY, 2002, 36 (04) : 604A - 604A
  • [7] Chronic hepatitis C: Treatment of pegylated interferon/ribavirin nonresponders
    Shiffman M.L.
    Current Gastroenterology Reports, 2006, 8 (1) : 46 - 52
  • [8] Chronic hepatitis C: Treatment of pegylated interferon/ribavirin nonresponders
    Shiffman M.L.
    Current Hepatitis Reports, 2006, 5 (3) : 114 - 120
  • [9] Individualized treatment of chronic hepatitis C with pegylated interferon and ribavirin
    Carvalho-Filho, Roberto J.
    Dalgard, Olav
    PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2010, 3 : 1 - 13
  • [10] Pegylated interferon for treatment in hemodialysis patients with chronic hepatitis C
    Koksal, I
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 (03) : 491 - 494
12345